免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With

NCT:NCT07819474 · NOT_YET_RECRUITING

NCT IDNCT07819474
狀態NOT_YET_RECRUITING
開始日期2027-02-18
完成時間2030-08-31
SponsorM.D. Anderson Cancer Center (OTHER)
First posted
Last updated

簡要摘要

To find out if the amount of CD8 immune cells at the place where TIL cells are collected is linked to how well a patient responds to treatment.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑